Literature DB >> 12823751

Serologic analysis of three cases of neonatal alloimmune thrombocytopenia associated with HLA antibodies.

Satoshi Saito1, Masao Ota, Yumi Komatsu, Satoshi Ota, Shigeru Aoki, Kenichi Koike, Izumi Tokunaga, Takahisa Tsuno, Goro Tsuruta, Tetsuo Kubo, Hirofumi Fukushima.   

Abstract

BACKGROUND: Neonatal alloimmune thrombocytopenia (NAIT) is caused when maternal alloantibodies react with paternally inherited antigens present on the fetal PLTs, a reaction mainly due to antibodies against human PLT antigens. Cases in which NAIT has been caused by HLA antibodies are relatively rare. In this study, three cases of NAIT associated with HLA antibodies that occurred in a 1-year period are reported. STUDY DESIGN AND METHODS: The presence of HLA antibodies in these three NAIT case studies was elucidated by examining reactions of the neonatal and maternal sera with lymphocytes, PLTs, and beads from an HLA antibody screening test (FlowPRA, One Lambda Inc.). Absorption and elution tests with paternal cells were also conducted. In addition, the influence of titer and specificity of HLA antibodies on NAIT was analyzed in light of 24 other documented cases in Japan.
RESULTS: In the three case studies presented herein, antibodies against human PLT antigens were found in neither the maternal nor neonatal sera, while specific HLA antibodies were identified in both sera. Absorption of maternal serum with paternal PLTs eliminated the reactivity against paternal PLTs and lymphocytes.
CONCLUSION: Transplacental passage of maternal HLA antibodies was observed in the three neonates cited in the present study.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12823751     DOI: 10.1046/j.1537-2995.2003.00429.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  8 in total

Review 1.  Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management.

Authors:  Julie A Peterson; Janice G McFarland; Brian R Curtis; Richard H Aster
Journal:  Br J Haematol       Date:  2013-02-06       Impact factor: 6.998

2.  Neonatal alloimmune thrombocytopenia associated with maternal-fetal incompatibility for blood group B.

Authors:  Brian R Curtis; Andrea Fick; Andrew J Lochowicz; Janice G McFarland; Robert H Ball; Julie Peterson; Richard H Aster
Journal:  Transfusion       Date:  2007-11-19       Impact factor: 3.157

3.  A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and C4d.

Authors:  JoonHo Lee; Roberto Romero; Yi Xu; Jung-Sun Kim; Vanessa Topping; Wonsuk Yoo; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Sonia S Hassan; Bo Hyun Yoon; Chong Jai Kim
Journal:  PLoS One       Date:  2011-02-04       Impact factor: 3.240

Review 4.  The HLA system: genetics, immunology, clinical testing, and clinical implications.

Authors:  Sung Yoon Choo
Journal:  Yonsei Med J       Date:  2007-02-28       Impact factor: 2.759

Review 5.  Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities.

Authors:  Heidi Tiller; Anne Husebekk; Maria Therese Ahlen; Tor B Stuge; Bjørn Skogen
Journal:  Int J Womens Health       Date:  2017-04-19

Review 6.  Aplastic anemia during pregnancy: a review of obstetric and anesthetic considerations.

Authors:  Efrain Riveros-Perez; Amy C Hermesch; Linda A Barbour; Joy L Hawkins
Journal:  Int J Womens Health       Date:  2018-02-28

Review 7.  Human Leukocyte Antigen Diversity: A Southern African Perspective.

Authors:  Mqondisi Tshabalala; Juanita Mellet; Michael S Pepper
Journal:  J Immunol Res       Date:  2015-08-12       Impact factor: 4.818

8.  Pathogenicity of Bovine Neonatal Pancytopenia-associated vaccine-induced alloantibodies correlates with Major Histocompatibility Complex class I expression.

Authors:  Lindert Benedictus; Rutger D Luteijn; Henny Otten; Robert Jan Lebbink; Peter J S van Kooten; Emmanuel J H J Wiertz; Victor P M G Rutten; Ad P Koets
Journal:  Sci Rep       Date:  2015-08-03       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.